Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. EBITDA 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2012 to 2014. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Catalyst Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2014 was -3.5 M.
- Catalyst Pharmaceuticals Inc. annual ebitda for 2013 was -10.3 M, a 97.48% increase from 2012.
- Catalyst Pharmaceuticals Inc. annual ebitda for 2012 was -5.2 M.
EBITDA
QUARTERLY · $B
Catalyst Pharmaceuticals Inc. EBITDA — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) ebitda over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPRX's ebitda history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.